Dear Thomas, The Alumni Community of ESB Business School congratulates you to your new role and wishes you all the best for 2012!
The Supervisory Board of Fresenius Kabi AG today announced changes in the Management Board of Fresenius Kabi. Effective March 1, 2012 Thomas Mechtersheimer, who has been Senior Vice President for Fresenius Medical Care South Asia Pacific, will join the Fresenius Kabi AG Management Board as Deputy Member and will assume the position of President of region Asia Pacific. As of January 1, 2013 Thomas Mechtersheimer will become a full Member of the Management Board of Fresenius Kabi AG.
Fresenius Kabi is the market leader in infusion therapy and clinical nutrition in Europe and holds leading positions in important countries of Latin America and the Asia-Pacific region. Fresenius Kabi is focused on the therapy and care of critically and chronically ill patients inside and outside the hospital. Its portfolio comprises a wide range of IV drugs, infusion therapies, clinical nutrition products as well as the related medical devices. Fresenius Kabi has around 24 thousand employees worldwide. In 2010, Fresenius Kabi's sales were €3,672 million and the company's EBIT was €737 million.
Thomas Mechtersheimer has been Senior Vice President for Fresenius Medical Care South Asia Pacific since 2007 and currently reports directly to Roberto Fusté, Chief Executive Officer of Fresenius Medical Care Asia Pacific. Over the years, Thomas significantly contributed to the growth of Fresenius Medical Care in Asia and has a deep understanding of the Asian market dynamics. Thomas joined Fresenius in 1995 and has since held several executive positions within the Asian organization. Prior to joining Fresenius Medical Care, he worked in Industrial Automation and Special Machinery companies, both in Sales as well as in Technical Services. Thomas studied International Business at the Reutlingen University, Germany.
Rainer Baule, CEO and President of Fresenius Kabi AG, said: “We are very pleased with the appointments of Mats as my successor and Thomas as new Board Member of Fresenius Kabi. [...] Thomas is an excellent successor of Mats. With his extensive experience and his profound knowledge of the Asian Pacific market, I am confident Thomas will make significant contributions to continue the successful growth of Fresenius Kabi’s business in this region. I look forward to working closely with both.”
Ulf Mark Schneider, CEO of Fresenius and Chairman of the Supervisory Board of Fresenius Kabi AG, said: “Under Rainer Baule’s leadership, Fresenius Kabi has grown significantly and developed into a global player in health care. This is the right time to begin a smooth transition of leadership. [...] Thomas Mechtersheimer brings valuable international management experience and a deep understanding of the health care market dynamics that will be essential for the continued growth of our Fresenius Kabi business in Asia Pacific.[...]”.